Works matching AU Mita, Alain


Results: 55
    1
    2
    3

    A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

    Published in:
    Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571
    By:
    • Hong, David;
    • Rasco, Drew;
    • Veeder, Michael;
    • Luke, Jason J.;
    • Chandler, Jason;
    • Balmanoukian, Ani;
    • George, Thomas J.;
    • Munster, Pamela;
    • Berlin, Jordan D.;
    • Gutierrez, Martin;
    • Mita, Alain;
    • Wakelee, Heather;
    • Samakoglu, Selda;
    • Guan, Shanhong;
    • Dimery, Isaiah;
    • Graef, Thorsten;
    • Borazanci, Erkut
    Publication type:
    Article
    4
    5
    6

    Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

    Published in:
    2017
    By:
    • Mita, Monica M;
    • Mita, Alain C;
    • Moseley, Jennifer L;
    • Poon, Jennifer;
    • Small, Karen A;
    • Jou, Ying-Ming;
    • Kirschmeier, Paul;
    • Zhang, Da;
    • Zhu, Yali;
    • Statkevich, Paul;
    • Sankhala, Kamelesh K;
    • Sarantopoulos, John;
    • Cleary, James M;
    • Chirieac, Lucian R;
    • Rodig, Scott J;
    • Bannerji, Rajat;
    • Shapiro, Geoffrey I
    Publication type:
    journal article
    7
    8

    Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1113, doi. 10.1007/s00280-014-2572-z
    By:
    • Sarantopoulos, John;
    • Mita, Alain;
    • Wade, James;
    • Morris, John;
    • Rixe, Olivier;
    • Mita, Monica;
    • Dedieu, Jean-François;
    • Wack, Claudine;
    • Kassalow, Laurent;
    • Craig Lockhart, A.
    Publication type:
    Article
    9
    10

    Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 77, doi. 10.1007/s00280-014-2479-8
    By:
    • Mahalingam, Devalingam;
    • Malik, Laeeq;
    • Beeram, Muralidhar;
    • Rodon, Jordi;
    • Sankhala, Kamalesh;
    • Mita, Alain;
    • Benjamin, Daniel;
    • Ketchum, Norma;
    • Michalek, Joel;
    • Tolcher, Anthony;
    • Wright, John;
    • Sarantopoulos, John
    Publication type:
    Article
    11
    12
    13
    14
    15

    Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
    By:
    • Chia-Chi Lin;
    • Calvo, Emiliano;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Sarantopoulos, John;
    • Mita, Alain C.;
    • Preston, Glenn G.;
    • Mita, Monica M.;
    • Rodon, Jordi;
    • Mays, Theresa;
    • I.-Tien Yeh;
    • O'Rourke, Pat;
    • Takimoto, Chris H.;
    • Dancey, Janet E.;
    • Chen, Helen;
    • Tolcher, Anthony W.
    Publication type:
    Article
    16
    17
    18

    A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 4, p. 517, doi. 10.1007/s11523-023-00965-7
    By:
    • Bauer, Todd M.;
    • Moore, Kathleen N.;
    • Rader, Janet S.;
    • Simpkins, Fiona;
    • Mita, Alain C.;
    • Beck, J. Thaddeus;
    • Hart, Lowell;
    • Chu, Quincy;
    • Oza, Amit;
    • Tinker, Anna V.;
    • Imedio, Esteban Rodrigo;
    • Kumar, Sanjeev;
    • Mugundu, Ganesh;
    • Jenkins, Suzanne;
    • Chmielecki, Juliann;
    • Jones, Suzanne;
    • Spigel, David;
    • Fu, Siqing
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26

    Quantitative Nodal Burden and Mortality Across Solid Cancers.

    Published in:
    2022
    By:
    • Nguyen, Anthony T;
    • Luu, Michael;
    • Nguyen, Vina P;
    • Lu, Diana J;
    • Shiao, Stephen L;
    • Kamrava, Mitchell;
    • Atkins, Katelyn M;
    • Mita, Alain C;
    • Scher, Kevin S;
    • Spratt, Daniel E;
    • Faries, Mark B;
    • Daskivich, Timothy J;
    • Lin, De-Chen;
    • Chen, Michelle M;
    • Clair, Jon Mallen-St;
    • Sandler, Howard M;
    • Ho, Allen S;
    • Zumsteg, Zachary S
    Publication type:
    journal article
    27
    28
    29

    Baseline weight recovery and mortality risk in head and neck cancer.

    Published in:
    Head & Neck, 2025, v. 47, n. 1, p. 139, doi. 10.1002/hed.27898
    By:
    • Bastien, Amanda J.;
    • Amin, Luv;
    • Vasquez, Missael;
    • Cong, Iris;
    • Luu, Michael;
    • Laszlo, Meghan;
    • Yen, Saori;
    • Thompson, Heather;
    • Teitelbaum, Elana L.;
    • Jang, Julie K.;
    • Mita, Alain C.;
    • Scher, Kevin S.;
    • Moyers, Justin;
    • Mallen‐St. Clair, Jon;
    • Walgama, Evan S.;
    • Zumsteg, Zachary S.;
    • Ho, Allen S.
    Publication type:
    Article
    30
    31
    32
    33

    Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.

    Published in:
    Investigational New Drugs, 2023, v. 41, n. 2, p. 284, doi. 10.1007/s10637-023-01342-x
    By:
    • Jimeno, Antonio;
    • Baranda, Joaquina;
    • Iams, Wade T.;
    • Park, Jong Chul;
    • Mita, Monica;
    • Gordon, Michael S.;
    • Taylor, Matthew;
    • Dhani, Neesha;
    • Leal, Alexis D.;
    • Neupane, Prakash;
    • Eng, Cathy;
    • Yeku, Oladapo;
    • Mita, Alain;
    • Moser, Justin C.;
    • Butler, Marcus;
    • Loughhead, Scott M.;
    • Jennings, Julia;
    • Miselis, Nathan R.;
    • Ji, Rui-Ru;
    • Nair, Nitya
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Combined autophagy and HDAC inhibition.

    Published in:
    Autophagy, 2014, v. 10, n. 8, p. 1403, doi. 10.4161/auto.29231
    By:
    • Mahalingam, Devalingam;
    • Mita, Monica;
    • Sarantopoulos, John;
    • Wood, Leslie;
    • Amaravadi, Ravi K.;
    • Davis, Lisa E.;
    • Mita, Alain C.;
    • Curiel, Tyler J.;
    • Espitia, Claudia M.;
    • Nawrocki, Steffan T.;
    • Giles, Francis J.;
    • Carew, Jennifer S.
    Publication type:
    Article
    44

    Nodal staging convergence for HPV− and HPV+ oropharyngeal carcinoma.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 10, p. 1590, doi. 10.1002/cncr.33414
    By:
    • Ho, Allen S.;
    • Luu, Michael;
    • Kim, Sungjin;
    • Tighiouart, Mourad;
    • Mita, Alain C.;
    • Scher, Kevin S.;
    • Mallen‐St. Clair, Jon;
    • Walgama, Evan S.;
    • Lin, De‐Chen;
    • Nguyen, Anthony T.;
    • Zumsteg, Zachary S.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50